These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35325155)

  • 1. Rapid determination of ceftazidime/avibactam susceptibility of carbapenemase-producing Enterobacterales directly from blood cultures: a comparative evaluation of EUCAST disc diffusion RAST and direct Etest® RAST.
    Bianco G; Boattini M; Comini S; Iannaccone M; Cavallo R; Costa C
    J Antimicrob Chemother; 2022 May; 77(6):1670-1675. PubMed ID: 35325155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against
    Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F
    Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully Automated EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) from Positive Blood Cultures: Diagnostic Accuracy and Implementation.
    Cherkaoui A; Schorderet D; Azam N; Crudeli L; Fernandez J; Renzi G; Fischer A; Schrenzel J
    J Clin Microbiol; 2022 Oct; 60(10):e0089822. PubMed ID: 36173195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid antimicrobial susceptibility of Enterobacteriaceae by disk diffusion directly from blood culture bottles using the EUCAST RAST breakpoints.
    Martins A; Wink P; Pereira D; Souza A; Aquino V; Barth A
    J Glob Antimicrob Resist; 2020 Sep; 22():637-642. PubMed ID: 32512237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of EUCAST Direct Rapid Antimicrobial Susceptibility Test Method in Blood Culture Bottles with Positive Signal].
    Erdoğan G; Karakoç AE; Yücel M; Yağcı S
    Mikrobiyol Bul; 2021 Oct; 55(4):626-634. PubMed ID: 34666661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China.
    Wang Q; Zhang F; Wang Z; Chen H; Wang X; Zhang Y; Li S; Wang H
    BMC Microbiol; 2020 Jun; 20(1):187. PubMed ID: 32600252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles.
    Soo YT; Waled SNMB; Ng S; Peh YH; Chew KL
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):993-998. PubMed ID: 31955354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing breakpoints for amoxicillin/clavulanate and ampicillin/sulbactam for rapid antimicrobial susceptibility testing directly from positive blood culture bottles.
    König E; Iser J; Zechner-Sammer T; Friedl H; Krause R; Valentin T; Leitner E; Steinmetz I; Zollner-Schwetz I
    J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36951904
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.
    Koeth LM; Matuschek E; Kahlmeter G; Stone G
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1047-1053. PubMed ID: 29603034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
    Piérard D; Stone GG
    BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical Performance and Potential Clinical Utility of EUCAST Rapid Antimicrobial Susceptibility Testing in Blood Cultures after Four Hours of Incubation.
    Ekwall-Larson A; Fröding I; Mert B; Åkerlund A; Özenci V
    Microbiol Spectr; 2023 Feb; 11(2):e0500122. PubMed ID: 36809027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime/avibactam susceptibility by three different susceptibility testing methods in carbapenemase-producing Gram-negative bacteria from Australia.
    Sherry NL; Baines SL; Howden BP
    Int J Antimicrob Agents; 2018 Jul; 52(1):82-85. PubMed ID: 29499316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16-20 Hours Reading Time.
    Bianco G; Lombardo D; Ricciardelli G; Boattini M; Comini S; Cavallo R; Costa C; Ambretti S
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): activity of ceftazidime/avibactam against Enterobacterales isolated from urine.
    Giani T; Antonelli A; Sennati S; Di Pilato V; Chiarelli A; Cannatelli A; Gatsch C; Luzzaro F; Spanu T; Stefani S; Rossolini GM
    J Antimicrob Chemother; 2020 Apr; 75(4):979-983. PubMed ID: 31958125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).
    Ko WC; Stone GG
    Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):14. PubMed ID: 32238155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
    Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
    Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality.
    Tayşi MR; Öcal D; Çiçek Şentürk G; Çalişkan E; Çelik B; Şencan İ
    J Antimicrob Chemother; 2024 Jul; 79(7):1540-1546. PubMed ID: 38725249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Committee on Antimicrobial Susceptibility Testing-Recommended Rapid Antimicrobial Susceptibility Testing of
    Park JM; Kwon M; Hong KH; Lee H; Yong D
    Ann Lab Med; 2023 Sep; 43(5):443-450. PubMed ID: 37080745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.